JTT-851

· Akros Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JTT-851, covering 2013-08-01 to 2013-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus [Phase 2]